RareCyte
Developer of technologies for the analysis of rare and single cells in the blood. The company's technologies enable convenient preparation and sophisticated multiparametric phenotypic analysis of rare cells including individual rare cell capture and retrieval for genomic analysis. Its technology platform has two integrated components AccuCyte (blood separation system) and CyteFinder (an instrument for cell imaging…
Funding snapshot
About
Developer of technologies for the analysis of rare and single cells in the blood. The company's technologies enable convenient preparation and sophisticated multiparametric phenotypic analysis of rare cells including individual rare cell capture and retrieval for genomic analysis. Its technology platform has two integrated components AccuCyte (blood separation system) and CyteFinder (an instrument for cell imaging and analysis). Founded in 2009, headquartered in Seattle, United States. RareCyte operates in the Genomics, Life Sciences Platforms and Tools, Clinical Genomics sectors. The company focuses on Detection and Quantification, NGS Reagents. The company has raised $114.3M in Series C funding. Notable investors include Health Quest Capital, 5AM Ventures, Telegraph Hill Partners, F-Prime Capital, Arboretum Ventures, Agilent, among others.
Business model
Genomics > Enabling Technologies > Kits and Reagents > Detection and Quantification,
Life Sciences Platforms and Tools > Research Reagents and Kits > Genomics > NGS Reagents
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.